To investigate the clinical value of NDRG1 in NPC progression, 20 NPC and NPC metastatic tissues and 20 normal cases were used for IHC staining with the NDRG1 antibody. This evidence concerns the gene NDRG1 and nasopharyngeal carcinoma.